Inflammatory markers and risk of cardiovascular mortality in relation to diabetes status in the HUNT study.
Autor: | Løfblad L; Department of Clinical Chemistry, St. Olavs University Hospital, Trondheim, Norway. lena.lofblad@stolav.no., Hov GG; Department of Clinical Chemistry, St. Olavs University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, NTNU-Norwegian University of Science and Technology, Trondheim, Norway., Åsberg A; Department of Clinical Chemistry, St. Olavs University Hospital, Trondheim, Norway., Videm V; Department of Clinical and Molecular Medicine, NTNU-Norwegian University of Science and Technology, Trondheim, Norway.; Department of Immunology and Transfusion Medicine, St. Olavs University Hospital, Trondheim, Norway. |
---|---|
Jazyk: | angličtina |
Zdroj: | Scientific reports [Sci Rep] 2021 Aug 02; Vol. 11 (1), pp. 15644. Date of Electronic Publication: 2021 Aug 02. |
DOI: | 10.1038/s41598-021-94995-8 |
Abstrakt: | Inflammatory markers have been associated with increased risk of cardiovascular mortality in general populations. We assessed whether these associations differ by diabetes status. From a population-based cohort study (n = 62,237) we included all participants with diabetes (n = 1753) and a control group without diabetes (n = 1818). Cox regression models were used to estimate hazard ratios (HRs) with 95% confidence intervals (CI) for possible associations with cardiovascular mortality of 4 different inflammatory markers; C-reactive protein (CRP), calprotectin, neopterin and lactoferrin. During a median follow-up of 13.9 years, 728 (20.4%) died from cardiovascular disease (CVD). After adjustment for age, sex and diabetes, the associations of all inflammatory markers with risk of cardiovascular mortality were log-linear (all P ≤ 0.017 for trend) and did not differ according to diabetes status (all P ≥ 0.53 for interaction). After further adjustments for established risk factors, only CRP remained independently associated with cardiovascular mortality. HRs were 1.22 (1.12-1.32) per standard deviation higher log (© 2021. The Author(s).) |
Databáze: | MEDLINE |
Externí odkaz: |